Sobi is an international specialty healthcare company dedicated to rare diseases. Our mission is to develop and deliver innovative therapies and services to improve the lives of patients.
Sobi has been involved in the development and manufacturing ofrecombinant protein drugssince the technology was first developed more than30 years ago.
We want to make a differenceto people with rare diseases.
By working closely with patients and their relatives we learn about their daily challenges and needs.
Sobi Earnings Report Jan - Sept 2013.pdf
pdf-format, 1.8 MB
Sobi Earnings Report Jan - June 2013.pdf
pdf-format, 1.84 MB
Sobi Earnings Report Jan - March 2013.pdf
pdf-format, 1.94 MB
Annual Report 2012
pdf-format, 5.12 MB
Full Year Report 2012
pdf-format, 556 KB
Swedish Orphan Biovitrum AB (publ)
SE-112 76 Stockholm, SwedenPhone: +46 8 697 20 00
© Swedish Orphan Biovitrum AB, 2013